Respiratory diagnostics are the medical products and technologies that are used to diagnose respiratory diseases and disorders in patients. Respiratory diagnostics is effective as it can diagnose diseases at an early stage. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Based on anatomical features, the respiratory system has been segmented into the upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises the pharynx, larynx, and nasal passages, while the lower respiratory tract includes the trachea, lungs, and bronchi. Respiratory disorders, or lung diseases, are disorders such as asthma, cystic fibrosis, emphysema, lung cancer, mesothelioma, pulmonary hypertension, and tuberculosis. If left untreated, lung disease can produce health complications, problematic symptoms, and life-threatening conditions.

Market Dynamics

Development activities such as product launches, approvals, acquisitions, and mergers, among other, are driving the overall market growth. For instance, in November 2021, Cipla Limited, an multinational pharmaceutical company in India, launched Spirofy, India's pneumotach-based portable, wireless Spirometer, on World COPD Day. With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis in India. Such developments are anticipated to contribute to the market growth over the forecast period. For instance, in September 2021, Roche, manufacturing medicines in oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. Roche which also specializes in in vitro diagnostics and tissue-based cancer diagnostics, launched three molecular polymerase chain reaction (PCR) diagnostic test panels to simultaneously detect and differentiate common respiratory pathogens. Therefore, such advancements in the segment are expected to fuel segment growth.

Key features of the study:

• This report provides an in-depth analysis of the global respiratory disease testing market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global respiratory disease testing market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include CareFusion Corporation, Carestream Health, Inc., COSMED, Futuremed America, Inc., GE Healthcare, MGC Diagnostics Corporation, ndd Medical Technologies, Inc., Nihon Kohden Corporation, Perkin Elmer, Inc., FUJIFILM Healthcare Corporation, Philips Healthcare,Roche Healthcare, Beckton Dickinson and Company, Koninklijke Philips N.V. ResMed Inc., Medtronic, Abbott Diagnostics, and Quest Diagnostics.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global respiratory disease testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global respiratory disease testing

Detailed Segmentation:

• Global Respiratory Disease Testing Market, By Test Type:
  • Imaging Test
  • Spirometry
  • Peak Flow Test
  • Blood Gas Test
  • Lung Volume Test
  • Others
• Global Respiratory Disease Testing Market, By End User:
  • Hospitals
  • Physician Offices
  • Clinical Laboratories
• Global Respiratory Disease Testing Market, By Region:
  • North America
    
    • U.S.
    • Canada
  • Latin America
    
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • CareFusion Corporation 
  • Carestream Health, Inc.
  • COSMED
  • Futuremed America, Inc.
  • GE Healthcare
  • MGC Diagnostics Corporation
  • ndd Medical Technologies, Inc.
  • Nihon Kohden Corporation
  • Perkin Elmer, Inc.
  • FUJIFILM Healthcare Corporation
  • Philips Healthcare
  • Roche Healthcare
  • Beckton Dickinson and Company
  • Koninklijke Philips N.V.
  • ResMed Inc.
  • Medtronic
  • Abbott Diagnostics
  • Quest Diagnostics.